FindTrial
Sign In

Effectiveness of HFNC Vs non rebreathing mask for oxygen therapy in COVID 19 pneumonia

Randomized Controlled Trial to evaluate the effectiveness of HFNC and standard non-rebreathing mask for oxygen therapy in moderate category COVID 19 pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030829
Enrollment
30
Registered
2021-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J962- Acute and chronic respiratory failure Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: High Flow Nasal Cannula (HFNC) group: Group 1 will comprise of patients treated with High flow Nasal cannula. HFNC set at 40-60 L/mt , FiO2- 0.8-1adjusted to maintain SpO2 SpO2 â?¥ 96-

Sponsors

Government Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pneumonia with no signs of severe disease with Clinical features of dyspnoea, hypoxia, fever, cough Spo2-

Exclusion criteria

Exclusion criteria: Patients in severe category of COVID 19

Design outcomes

Primary

MeasureTime frame
Primary outcomes noted will be number of patients and time to progression to severe disease.Timepoint: 0,1,2 to 14 days—

Secondary

MeasureTime frame
Secondary outcome noted will be PaO2/FiO2 ratio, patient tolerance & acceptability will be assessed and Length of hospital stay will be recorded.Timepoint: 0,1,2, to 14 days—

Countries

India

Contacts

Public ContactDr Nazia Nazir

Government Institute of Medical sciences

nazunazir@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026